These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22432713)

  • 1. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
    Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
    J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel dual-action compounds targeting the adenosine A(2A) receptor and adenosine transporter for neuroprotection.
    Chen JB; Liu EM; Chern TR; Yang CW; Lin CI; Huang NK; Lin YL; Chern Y; Lin JH; Fang JM
    ChemMedChem; 2011 Aug; 6(8):1390-400. PubMed ID: 21692183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
    El-Tayeb A; Gollos S
    Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.
    Hou X; Majik MS; Kim K; Pyee Y; Lee Y; Alexander V; Chung HJ; Lee HW; Chandra G; Lee JH; Park SG; Choi WJ; Kim HO; Phan K; Gao ZG; Jacobson KA; Choi S; Lee SK; Jeong LS
    J Med Chem; 2012 Jan; 55(1):342-56. PubMed ID: 22142423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
    Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
    Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual acting antioxidant A1 adenosine receptor agonists.
    Gregg A; Bottle SE; Devine SM; Figler H; Linden J; White P; Pouton CW; Urmaliya V; Scammells PJ
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5437-41. PubMed ID: 17689079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors.
    Park HM; Lee JH; Yaoyao J; Jun HJ; Lee SJ
    Biochem Biophys Res Commun; 2011 Jan; 404(1):345-8. PubMed ID: 21134357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
    Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
    J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Carrion MD; Cara LC; Moorman AR; Varani K; Borea PA
    J Med Chem; 2007 Jan; 50(2):374-80. PubMed ID: 17228880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adenosine modified with a boron cluster pharmacophore on reactive oxygen species production by human neutrophils.
    Bednarska K; Olejniczak AB; Piskala A; Klink M; Sulowska Z; Lesnikowski ZJ
    Bioorg Med Chem; 2012 Nov; 20(22):6621-9. PubMed ID: 23063523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
    Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G
    J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine A(2A) and A(2B) receptor activation on signaling pathways and cytokine production in human uroepithelial cells.
    Säve S; Persson K
    Pharmacology; 2010; 86(3):129-37. PubMed ID: 20689344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor.
    van Tilburg EW; Gremmen M; von Frijtag Drabbe Künzel J; de Groote M; IJzerman AP
    Bioorg Med Chem; 2003 May; 11(10):2183-92. PubMed ID: 12713828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
    Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
    J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
    van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
    J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor.
    Preti D; Baraldi PG; Saponaro G; Romagnoli R; Aghazadeh Tabrizi M; Baraldi S; Cosconati S; Bruno A; Novellino E; Vincenzi F; Ravani A; Borea PA; Varani K
    J Med Chem; 2015 Apr; 58(7):3253-67. PubMed ID: 25780876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
    Harada N; Okajima K; Murakami K; Usune S; Sato C; Ohshima K; Katsuragi T
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1034-42. PubMed ID: 10945856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.